Picard Medical, Inc.
Here’s whether Picard Medical, Inc. (PMI) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bearish.
Concerns: trading below the 200-day MA (long-term downtrend); below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-10.11% over 10 days); RSI 18 — oversold; 3-month momentum negative (-59.4%); rising volume on a downtrend (distribution, 1.36x avg). Currently 99.5% off its 52-week high. Score: -6/7.
PMI is trading below its 200-day MA ($60.64) — a key warning sign the longer-term trend is under pressure. An RSI of 18.4 has dropped into oversold territory, which has historically preceded short-term bounces. With ~11 months of trading history, the return since first available bar is -98.6%. The current 99.5% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.